%0 Journal Article
%T Efficacy and Safety of Modified Pranlukast (Prakanon£¿) Compared with Pranlukast (Onon£¿): A Randomized, Open-Label, Crossover Study
%A Hunam Kim
%A Jin H. Lee
%A Jung H. Chang
%A Seo W. Kim
%A Sung S. Shim
%A Yon J. Ryu
%A Yoo K. Kim
%J Archive of "The Open Respiratory Medicine Journal".
%D 2016
%R 10.2174/1874306401610010036
%X Pranlukast is a leukotriene receptor antagonist (LTRA) that is used as an additional controller of mild to moderate asthma. This study compared the efficacy and side effects of two bioequivalent preparations of pranlukast: original pranlukast (Onon£¿; Ono Pharmaceutical, Japan) and a modified formulation of pranlukast (Prakanon£¿; Yuhan Co, Korea) in patients with mild to moderate asthma
%K Asthma
%K Asthma control test
%K Leukotriene receptor antagonist
%K Pranlukast
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951783/